Galmed Pharmaceuticals Ltd. (GLMD)
USD 2.9
(-3.65%)
USD 2.9
(-3.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 2.03 Million |
| Cost of Revenue | 31 Thousand | 35 Thousand | 42 Thousand | 39 Thousand | 35 Thousand | - |
| Gross Profit | -31 Thousand | -35 Thousand | -42 Thousand | -39 Thousand | -35 Thousand | 2.03 Million |
| Operating Expenses | -7.49 Million | 17.65 Million | 32.88 Million | 30.21 Million | 22.37 Million | 12.75 Million |
| Selling, General and Administrative Expenses | 3.92 Million | 4.65 Million | 5.66 Million | 4.12 Million | 4.19 Million | 4.44 Million |
| Research and Development Expenses | 3.56 Million | 12.99 Million | 27.22 Million | 26.08 Million | 18.18 Million | 8.31 Million |
| Other Expenses | -14.98 Million | - | - | - | - | - |
| Cost and Expenses | -7.49 Million | 17.65 Million | 32.88 Million | 30.21 Million | 22.37 Million | 12.75 Million |
| Operating Income | 7.49 Million | -17.65 Million | -32.88 Million | -30.21 Million | -22.37 Million | -10.71 Million |
| Interest Expense | 11 Thousand | 215 Thousand | 43 Thousand | 31 Thousand | 33 Thousand | 42 Thousand |
| Income Tax Expense | - | 705 Thousand | -519 Thousand | -1.16 Million | -1.92 Million | 75 Thousand |
| Earnings before Tax | -6.91 Million | -17.86 Million | -32.46 Million | -28.77 Million | -20.46 Million | -9.78 Million |
| Net Income | -6.91 Million | -18.57 Million | -31.94 Million | -27.61 Million | -18.54 Million | -9.85 Million |
| Earnings Per Share Basic | -30.05 | -11.08 | -19.48 | -19.46 | -13.17 | -8.15 |
| Earnings Per Share Diluted | -29.95 | -11.08 | -19.48 | -19.46 | -13.17 | -8.15 |
| Weighted Average Shares Outstanding | 230 Thousand | 1.67 Million | 1.63 Million | 1.41 Million | 1.4 Million | 1.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 230.79 Thousand | 1.67 Million | 1.63 Million | 1.41 Million | 1.4 Million | 1.2 Million |
| Gross Margin | - | - | - | - | - | 1.00 |
| EBIT Margin | - | - | - | - | - | -5.08 |
| Profit Margin | - | - | - | - | - | -4.84 |
| EBITDA | -7.46 Million | -17.61 Million | -32.83 Million | -30.17 Million | -22.34 Million | -10.32 Million |
| Earnings Before Tax Margin | - | - | - | - | - | -5.26 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 74 Thousand | 9000.00 | 31 Thousand | 6000.00 | 17 Thousand | 9000.00 |
| Gross Profit | -74 Thousand | -9000.00 | -31 Thousand | -6000.00 | -17 Thousand | -9000.00 |
| Operating Expenses | 1.14 Million | 1.39 Million | 7.46 Million | 2.14 Million | 1.46 Million | 1.87 Million |
| Selling, General and Administrative Expenses | 614 Thousand | 757 Thousand | - | 1.02 Million | 912 Thousand | 1.06 Million |
| Research and Development Expenses | 534 Thousand | 635 Thousand | - | 1.12 Million | 556 Thousand | 809 Thousand |
| Other Expenses | - | 635 Thousand | - | 1.12 Million | 556 Thousand | 809 Thousand |
| Cost and Expenses | 1.22 Million | 1.4 Million | 7.49 Million | 2.15 Million | 1.46 Million | 1.87 Million |
| Operating Income | -1.22 Million | -1.4 Million | -7.49 Million | -2.15 Million | -1.46 Million | -1.87 Million |
| Interest Expense | - | - | 11 Thousand | - | 5000.00 | - |
| Income Tax Expense | - | -34.27 Thousand | - | -37.81 Thousand | 47.58 Thousand | -113.08 Thousand |
| Earnings before Tax | -1.11 Million | -1.27 Million | -6.91 Million | -2.01 Million | -1.47 Million | -1.59 Million |
| Net Income | -1.11 Million | -1.27 Million | -6.91 Million | -2.01 Million | -1.47 Million | -1.59 Million |
| Earnings Per Share Basic | -2.13 | -0.23 | - | -0.40 | -0.24 | -0.95 |
| Earnings Per Share Diluted | -2.13 | -0.23 | - | -0.40 | -0.24 | -0.95 |
| Weighted Average Shares Outstanding | 524.56 Thousand | 5.46 Million | 230.79 Thousand | 5.04 Million | 6.24 Million | 1.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 524.56 Thousand | 5.46 Million | 230.79 Thousand | 5.04 Million | 6.24 Million | 1.68 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.14 Million | -1.39 Million | - | -2.14 Million | -1.46 Million | -1.86 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
SHJBF
019170
LSRCF
BAJEL
1317
NIITMTS